Star Sports Medicine Invests 190 Million Yuan in Wealth Products; Shares Up 3%

MT Newswires Live05-27

Star Sports Medicine (HKG:1609) subscribed to two wealth management products with a combined principal amount of 190 million yuan, according to a Tuesday Hong Kong bourse filing.

Shares of the medical device company were up nearly 3% in Wednesday afternoon trade.

The company subscribed to an 80 million yuan wealth management product issued by Agricultural Bank of China (HKG:1288, SHA:601288) on May 26 and a 110 million yuan product issued by Bank of Beijing on May 11, using its own funds.

The company said the subscriptions were part of its routine treasury management of idle funds and followed the maturity of earlier wealth management and structured deposit investments this month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment